May, 12-13 Florence
![]() |
![]() |
![]() |
![]() |
P05-01 | Long-term treatment with fibrates and ursodeoxycholic acid in people with primary sclerosing cholangitis is safe and associated with persistent clinical and biochemical improvement | Matteo Peviani | ![]() |
![]() |
|||
P01-01 | Acute hepatocytic loss of endosomal sorting complex Retromer increases proliferation of biliary epithelial cells (BECs) | Markus Barbosa | ![]() |
![]() |
|||
P04-01 | Chronic ketamine-induced sclerosing cholangitis associated with early inflammatory bowel disease after long term topical use | Gerond Lake-Bakaar MD. PhD, | ![]() |
![]() |
|||
P03-01 | CRISPR-engineered chemically-derived hepatic progenitor cancer organoid recapitulates intrahepatic cholangiocarcinoma carcinogenesis and pathophysiology | Michael Adisasmita | ![]() |
![]() |
|||
P02-1 | Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells | Ainhoa Lapitz | ![]() |
![]() |
|||
P02-02 | Functional dichotomy of biliary primary cilia in liver injury and cholangiocarcinoma development | Jinbiao Chen | ![]() |
![]() |
|||
P03-02 | Metabolic rewiring of cystic cholangiocytes improves mitochondrial dynamics and bioenergetics ameliorating the pathogenesis of polycystic liver disease in experimental models | Enara Markaide | ![]() |
![]() |
|||
P04-02 | Mice lacking the NO receptor develop biliary fibrosis and become worsen upon feeding Western diet | Muhammad Ashfaq Khan | ![]() |
![]() |
|||
P01-02 | An organotypic model of ductular reaction reveals a role of lipid biosynthesis in biliary cell activation | Giovanni Sorrentino | ![]() |
![]() |
|||
P05-2 | scRNA transcriptomics analysis of cellular cross talk in fibrocystin-defective mice revelas a central role for cholangiocytes, neutrophils and double-negative T cells | Zehra Syeda | ![]() |
![]() |
|||
P04-03 | Thy-1 expression in liver histology correlates with fibrosis grading in patients with primary biliary cholangitis | Mirjam Kolev | ![]() |
![]() |
|||
P05-03 | Claudin-1 is a therapeutic target for primary sclerosing cholangitis | Fabio Del Zompo | ![]() |
![]() |
|||
P03-3 | Large CD103 CD69 CD8 T cells consistently invade biliary epithelial cells in patients with primary biliary cholangitis | Scott Davies | ![]() |
![]() |
|||
P02-03 | Hematopoietic-biliary organoids as a model for liver development and injury | Susanna Quach | ![]() |
![]() |
|||
P01-03 | Quantitative MRCP differentiates between malignant and benign biliary obstructions | Sarah Finnegan | ![]() |
![]() |
|||
P03-04 | Targeting OX40 signalling to modulate regulatory T cells and reduce biliary fibrosis | Wei-Yu Lu | ![]() |
![]() |
|||
P01-04 | Characterizing and manipulating GPR35-dependent mast cell activity in PSC | Georg Schneditz | ![]() |
![]() |
|||
P04-04 | Primary biliary cholangitis symptoms are reduced in Mcpip1fl/flAlbCre mice after pharmacological treatment | Katarzyna Trzos | ![]() |
![]() |
|||
P05-04 | Dimethyl-fumarate attenuates cholestatic liver injury in mice | Ester Dohnalkova | ![]() |
![]() |
|||
P02-04 | Identification of the role of osteopontin in biliary atresia | Natalia Nieto | ![]() |
![]() |
|||
P03-05 | Combined inhibition of bile salt synthesis and intestinal bile salt uptake ameliorates cholestatic liver damage and reduces colonic bile salt levels in mice | Stan van de Graaf | ![]() |
![]() |
|||
P01-05 | Necroptosis contributes to liver inflammation and fibrosis in experimental primary sclerosing cholangitis | Pierre-Antoine Soret | ![]() |
![]() |
|||
P02-05 | Transcriptomic risk score predicts response to obeticholic acid and identifies genes linked with metabolic remodelling, autophagy, senescence and fibrosis in patients with PBC | Hussain Syed | ![]() |
![]() |
|||
P04-05 | Mertk-expressing macrophages promote the malignant features of cholangiocarcinoma cells | Mirella Pastore | ![]() |
![]() |
|||
P01-06 | Multimodal decoding of the mesenchymal landscape of human biliary fibrosis | David Wilson | ![]() |
![]() |
|||
P05-06 | Recurrence of primary sclerosing cholangitis after liver transplantation: a single center data | Elisa Catanzaro | ![]() |
![]() |
|||
P02-06 | CD8 T cells from patient with primary biliary cholangitis express e-cadherin upon T cell receptor activation and invade biliary epithelial cells through e-cadherin-beta-catenin interaction | Vincenzo Ronca | ![]() |
![]() |
|||
P04-06 | Biliary atrasia human cholangiocyte organoids demonstrate increased oxidative stress response | Yara Hamody | ![]() |
![]() |
|||
P03-06 | Beta-caryophyllene a CB2 specific agonist prevents the development of hepatopulmonary syndrome in experimental model of biliary cirrhosis | Akash Mourya | ![]() |
![]() |
|||
P04-07 | Oval cells as new players of the inflammatory response during cholestatic liver damage: role of the EGFR pathway | Aránzazu Sánchez | ![]() |
![]() |
|||
P02-07 | Mitochondrial dynamics and autophagy are disturbed in experimental models of primary biliary cholangitis, contributing to disease pathogenesis | Irune Lasa | ![]() |
![]() |
|||
P05-07 | Hepatic recompensation upon treatment with ursodeoxycholic acid in PBC patients with decompensated cirrhosis | Lukas Burghart | ![]() |
![]() |
|||
P01-07 | Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis | Maria Mercado-Gómez | ![]() |
![]() |
|||
P03-07 | Patient proteomic data and mouse model reinforce the proinflammatory role of CCL24 in cholestatic disease | Greenman Raanan | ![]() |
![]() |
|||
P02-08 | Identification of a functional relationship between MEK5-ERK5 pathway and hypoxia inducible factor 1-alfa | Alessio Menconi | ![]() |
![]() |
|||
P03-08 | Non-invasive evaluation of progression to primary biliary cholangitis in patients with positive antimitochondrial antibodies | MARTA ALONSO PEÑA | ![]() |
![]() |
|||
P04-08 | Radiomics features for risk stratification in primary sclerosing cholangitis: a proof-of-concept study | Laura Cristoferi | ![]() |
![]() |
|||
P01-08 | Harnessing immune dysregulation in the search for serum biomarkers for diagnosis and prognosis of primary sclerosing cholangitis | Lander Heyerick | ![]() |
![]() |
|||
P05-08 | Liver re-transplantation for recurrent primary sclerosing cholangitis: how far we can go? | Chiara Mazzarelli | ![]() |
![]() |
|||
P04-09 | Bile duct injury in mdr2 knockout mice can be repaired with n-acetylcysteine treatment | Adi Har-Zahav | ![]() |
![]() |
|||
P02-09 | Primary cilia as a targetable node between biliary injury, senescence and regeneration in liver transplantation | Sofia Ferreira Gonzalez | ![]() |
![]() |
|||
P01-09 | Beta 7 integrin and L-in contribute to cholestatic liver disease in mice | Agnes Seeger | ![]() |
![]() |
|||
P05-09 | Biliary senescence affects the transcriptomic landscape of murine hepatocytes | Marisa F. Ferreira | ![]() |
![]() |
|||
P03-09 | Primary sclerosing cholangitis with features of autoimmune hepatitis: phenotypic characterization and prognosis | Mirjam Kolev | ![]() |
![]() |
|||
P05-10 | Extracellular matrix remodeling in the progression of primary sclerosing cholangitis to cholangiocarcinoma: insights from an animal model | Massimiliano Cadamuro | ![]() |
![]() |
|||
P04-10 | Increased protein tyrosine phosphatase non-receptor type 2 activity in primary sclerosing cholangitis | Madita Determann | ![]() |
![]() |
|||
P02-10 | Neutrophils in the pathogenesis of primary sclerosing cholangitis | Nidhi Jalan-Sakrikar | ![]() |
![]() |
|||
P01-10 | Dynamics of spleen stiffness measurement in patients with primary biliary cholangitis predict disease progression: a pilot study | Micol Cittone | ![]() |
![]() |
|||
P03-10 | A3907, a systemic ASBT inhibitor, improves cholestasis and biliary fibrosis in mice by multi-organ activity and shows translational relevance to human | Francisco J. Caballero | ![]() |
![]() |
May, 12-13 Florence
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|